Dec 11, 2023 4:05 pm EST ResMed Secures Significant Victory in Patent Fight Against New York University
Dec 7, 2023 3:34 pm EST Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
Jul 5, 2023 4:05 pm EDT ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
Jun 8, 2023 9:00 am EDT PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
